Varicella Zoster Virus (VZV)
Use
Varicella Zoster Virus (VZV), a member of the human herpes virus family, causes two distinct clinical manifestations: chickenpox (varicella) and shingles (reactivation). Primary VZV infection may rarely result in complications including encephalitis or pneumonia. This immunohistochemistry antibody detects VZV in formalin‑fixed, paraffin‑embedded (FFPE) tissues, facilitating diagnosis of VZV‑related disease.
Special Instructions
Level of Service options include “Global” (technical + interpretation) and “Tech‑Only” (technical component only). The test is New York Approved: Yes. Specimen requirements: FFPE tissue block preferred, or one unbaked unstained H&E slide (required) plus two to three positively charged unstained slides cut 4‑5 microns. Blocks and slides must be clearly labeled with identifiers matching the requisition. For transport: use a cold pack not in direct contact with the specimen; New York State clients must provide date and time of collection.
Limitations
Not provided.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
FFPE block preferred; or one unbaked, unstained H&E slide (required) plus two to three positively charged unstained slides cut at 4‑5 microns.
Causes for Rejection
Block or slides with mismatched or unclear identifiers; unstained slides not positively charged or wrong cut thickness.